Orladeyo (berotralstat) is FDA indicated to treat Hereditary Angioedema
… FDA Approves Orladeyo (berotralstat) for Hereditary Angioedema patients …

Orladeyo (berotralstat) by BioCryst Pharmaceuticals Earns FDA Approval

A new cardiovascular agent treats Hereditary Angioedema (HAE)

John G. Baresky

Orladeyo’s oral formulation is a competitive advantage

BioCryst Pharmaceuticals may have an important brand and market access strategy over its rivals with Orladeyo as it can be taken orally. The HAE therapies of two competitors are administered by injection which could be considered by patients and prescribing physicians as less convenient:

  • Takhzyro (lanadelumab-flyo) is a monoclonal antibody (mAb) marketed by Takeda (NYSE: TAK) that was issued FDA approval in 2018

Orladeyo’s oral formulation is an added element to its market access strategy

BioCryst’s market access strategy will need to establish Orladeyo’s clinical and cost-effectiveness versus the CSL Behring and Takeda products with managed care organizations (MCOs), pharmacy benefits managers (PBMs) and specialty pharmacies as well as introduce it to the broad cardiology and internal medicine physician community nationwide.

BioCryst is a compact, R&D-focused biopharmaceutical enterprise

Founded in 1986, BioCryst (NASDAQ: BSX) is headquartered in Durham, North Carolina and operates an advanced research & development facility known as its Discovery Center of Excellence in Birmingham, Alabama. It is a commercial-stage biotech company that focuses on rare diseases.

The FDA has been on a roll with evaluating advanced new therapies for rare diseases and improving their availability to patients and medical professionals

The FDA has been heavily burdened with the challenges of COVID-19 but it has not abandoned the patients or clinicians seeking new drug treatments for oncology and rare diseases. Over the last several months, these are just some of the complex products that have passed the clinical scrutiny of the FDA and are now approved:

Authentic, fact-based healthcare content marketing writing for medical, business, academic, patient and consumer audiences https://www.BareSkyMarketing.com/